Matthew Tucker
5PUBLICATIONS
11CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Jan 31, 2025
Association between neutrophil-to-eosinophil ratio and efficacy outcomes with avelumab plus axitinib or sunitinib in patients with advanced renal cell carcinoma: post hoc analyses from the JAVELIN Renal 101 trial.Matthew Tucker, Yu-Wei Chen, Martin H Voss
|Aug 11, 2021
A Multi-institutional, Retrospective Analysis of Patients with Metastatic Renal Cell Carcinoma to Bone Treated with Combination Ipilimumab and Nivolumab.Kunal Desai, Landon Brown, Wei Wei
|Mar 03, 2021
<i>LRP1B</i> mutations are associated with favorable outcomes to immune checkpoint inhibitors across multiple cancer types.Landon C Brown, Matthew D Tucker, Ramy Sedhom
|Sep 23, 2020
Predicting Response to Immunotherapy in Metastatic Renal Cell Carcinoma.Matthew D Tucker, Brian I Rini
|Jul 05, 2019
Pembrolizumab in men with heavily treated metastatic castrate-resistant prostate cancer.Matthew D Tucker, Jason Zhu, Daniele Marin
Pageof 1
Frequent Collaborators
2 joint publications
Landon C Brown
2 joint publications
Tian Zhang
1 joint publications
Jason Zhu
1 joint publications
Daniel J George
1 joint publications
Andrew J Armstrong
1 joint publications
Matthew K Labriola
1 joint publications
Kunal Desai
1 joint publications
Kathryn Beckermann
1 joint publications
Moshe C Ornstein
1 joint publications
Martin H Voss
